These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26009224)

  • 1. Bivalirudin versus heparin use for patients undergoing PPCI.
    Schneider DJ
    Lancet; 2015 May; 385(9982):2044. PubMed ID: 26009224
    [No Abstract]   [Full Text] [Related]  

  • 2. Bivalirudin versus heparin use for patients undergoing PPCI.
    Shah R
    Lancet; 2015 May; 385(9982):2045. PubMed ID: 26009227
    [No Abstract]   [Full Text] [Related]  

  • 3. Bivalirudin versus heparin use for patients undergoing PPCI.
    Miyasaka M; Wada Y; Kami M
    Lancet; 2015 May; 385(9982):2044-5. PubMed ID: 26009225
    [No Abstract]   [Full Text] [Related]  

  • 4. Bivalirudin versus heparin use for patients undergoing PPCI.
    Steg PG; van't Hof AW; Zeymer U; Goldstein P
    Lancet; 2015 May; 385(9982):2043-4. PubMed ID: 26009223
    [No Abstract]   [Full Text] [Related]  

  • 5. Bivalirudin versus heparin use for patients undergoing PPCI - Authors' reply.
    Shahzad A; Stables RH
    Lancet; 2015 May; 385(9982):2045-6. PubMed ID: 26009226
    [No Abstract]   [Full Text] [Related]  

  • 6. Is the heat on HEAT-PPCI appropriate?
    Berger PB; Blankenship JC
    Lancet; 2014 Nov; 384(9957):1824-1826. PubMed ID: 25002176
    [No Abstract]   [Full Text] [Related]  

  • 7. HEAT-PPCI sheds light on consent in pragmatic trials.
    Shaw D
    Lancet; 2014 Nov; 384(9957):1826-1827. PubMed ID: 25002175
    [No Abstract]   [Full Text] [Related]  

  • 8. Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial.
    Shahzad A; Kemp I; Mars C; Wilson K; Roome C; Cooper R; Andron M; Appleby C; Fisher M; Khand A; Kunadian B; Mills JD; Morris JL; Morrison WL; Munir S; Palmer ND; Perry RA; Ramsdale DR; Velavan P; Stables RH;
    Lancet; 2014 Nov; 384(9957):1849-1858. PubMed ID: 25002178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bivalirudin reduces platelet and monocyte activation after elective percutaneous coronary intervention.
    Busch G; Steppich B; Sibbing D; Braun SL; Stein A; Groha P; Schömig A; Kastrati A; von Beckerath N; Ott I
    Thromb Haemost; 2009 Feb; 101(2):340-4. PubMed ID: 19190819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unfractionated heparin versus bivalirudin in patients undergoing primary percutaneous coronary intervention: a SWEDEHEART study.
    Grimfjärd P; Erlinge D; Koul S; Lagerqvist B; Svennblad B; Varenhorst C; James SK
    EuroIntervention; 2017 Mar; 12(16):2009-2017. PubMed ID: 28044990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of low-dose heparin with bivalirudin for ad-hoc transradial coronary interventions: experience from a single center.
    Singh A; Edasery D; Noor A; Bhasin N; Kaplan B; Jauhar R
    J Invasive Cardiol; 2011 Mar; 23(3):101-4. PubMed ID: 21364238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety of a bivalirudin-based approach in patients undergoing rotational atherectomy.
    Gurm HS; Rajagopal V; Bhatt DL; Ellis SG; Lincoff AM
    J Invasive Cardiol; 2007 May; 19(5):225-8. PubMed ID: 17476038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention.
    Kastrati A; Neumann FJ; Mehilli J; Byrne RA; Iijima R; Büttner HJ; Khattab AA; Schulz S; Blankenship JC; Pache J; Minners J; Seyfarth M; Graf I; Skelding KA; Dirschinger J; Richardt G; Berger PB; Schömig A;
    N Engl J Med; 2008 Aug; 359(7):688-96. PubMed ID: 18703471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bivalirudin: role in current percutaneous coronary intervention practice.
    West N
    Br J Hosp Med (Lond); 2005 Dec; 66(12):687-9. PubMed ID: 16417115
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of PAR-1 in patients undergoing percutaneous coronary intervention: effects of unfractionated heparin and bivalirudin.
    Eslam RB; Reiter N; Kaider A; Eichinger S; Lang IM; Panzer S
    Eur Heart J; 2009 Aug; 30(15):1831-6. PubMed ID: 19468011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical applications of bivalirudin in the cardiac catheterization laboratory.
    Thompson KA; Philip KJ; Schwarz ER
    J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):140-9. PubMed ID: 21097669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome initially treated with fondaparinux: results from an international, multicenter, randomized pilot study (SWITCH III).
    Waksman R; Bertrand O; Driesman M; Gruberg L; Rossi J; Mehta S; Swymelar S; Dvir D; Xue Z; Torguson R
    J Interv Cardiol; 2013 Apr; 26(2):107-13. PubMed ID: 23240743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile of bleeding and ischaemic complications with bivalirudin and unfractionated heparin after percutaneous coronary intervention.
    Iijima R; Ndrepepa G; Mehilli J; Byrne RA; Schulz S; Neumann FJ; Richardt G; Berger PB; Schömig A; Kastrati A
    Eur Heart J; 2009 Feb; 30(3):290-6. PubMed ID: 19147609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators.
    Bittl JA; Strony J; Brinker JA; Ahmed WH; Meckel CR; Chaitman BR; Maraganore J; Deutsch E; Adelman B
    N Engl J Med; 1995 Sep; 333(12):764-9. PubMed ID: 7643883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: results from the REPLACE-2 trial.
    Cohen DJ; Lincoff AM; Lavelle TA; Chen HL; Bakhai A; Berezin RH; Jackman D; Sarembock IJ; Topol EJ
    J Am Coll Cardiol; 2004 Nov; 44(9):1792-800. PubMed ID: 15519009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.